drugset / Trial / NCT01024491

Efficacy and Safety of Paroxetine Daily Doses of 15 mg and 20 mg in the Treatment of Premature Ejaculation

NCT01024491

Phase 3 Completed 174 enrolled MorePharma Corporation
RandomizedParallel-groupQuadruple-blindTreatment

Summary

As study to investigate the efficacy and safety of daily doses of paroxetine of 15 and 20 mg for the treatment of premature ejaculation

Timeline

Start
2008-08
Primary completion
2009-03
Completion
2009-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Paroxetine Small molecule 15 mg
Subject Paroxetine Small molecule 20 mg

Indications